AU599387B2 - Dentifrice compositions comprising hydroxyapatite in which glucanase is immobilized therein - Google Patents
Dentifrice compositions comprising hydroxyapatite in which glucanase is immobilized therein Download PDFInfo
- Publication number
- AU599387B2 AU599387B2 AU74600/87A AU7460087A AU599387B2 AU 599387 B2 AU599387 B2 AU 599387B2 AU 74600/87 A AU74600/87 A AU 74600/87A AU 7460087 A AU7460087 A AU 7460087A AU 599387 B2 AU599387 B2 AU 599387B2
- Authority
- AU
- Australia
- Prior art keywords
- hydroxyapatite
- immobilized
- glucanase
- dentifrice
- dextranase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims description 45
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title claims description 45
- 239000000551 dentifrice Substances 0.000 title claims description 35
- 239000000203 mixture Substances 0.000 title claims description 23
- 108010001682 Dextranase Proteins 0.000 claims description 19
- 108010005131 levanase Proteins 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 claims description 11
- 208000002925 dental caries Diseases 0.000 claims description 9
- 210000000214 mouth Anatomy 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 13
- 102000004169 proteins and genes Human genes 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 13
- 108010014251 Muramidase Proteins 0.000 description 12
- 102000016943 Muramidase Human genes 0.000 description 12
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 12
- 229960000274 lysozyme Drugs 0.000 description 12
- 239000004325 lysozyme Substances 0.000 description 12
- 235000010335 lysozyme Nutrition 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 9
- 239000003381 stabilizer Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000005498 polishing Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 208000002064 Dental Plaque Diseases 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 4
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- AIHDCSAXVMAMJH-GFBKWZILSA-N levan Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(CO[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 AIHDCSAXVMAMJH-GFBKWZILSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical class OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 239000008057 potassium phosphate buffer Substances 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 102000018832 Cytochromes Human genes 0.000 description 2
- 108010052832 Cytochromes Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229910052586 apatite Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- -1 terpene hydrocarbon Chemical class 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 241000861718 Chloris <Aves> Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- JJVNQNRVLYDOKY-UHFFFAOYSA-K [Na+].[Mg+2].[Cl-].[Cl-].[Cl-].[K+] Chemical compound [Na+].[Mg+2].[Cl-].[Cl-].[Cl-].[K+] JJVNQNRVLYDOKY-UHFFFAOYSA-K 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- KXKFFNJPSQCIQR-UHFFFAOYSA-L magnesium sodium dichloride Chemical compound [Na+].[Mg+2].[Cl-].[Cl-] KXKFFNJPSQCIQR-UHFFFAOYSA-L 0.000 description 1
- ANZKPYPDQZRQBD-UHFFFAOYSA-L magnesium;potassium;dichloride Chemical compound [Mg+2].[Cl-].[Cl-].[K+] ANZKPYPDQZRQBD-UHFFFAOYSA-L 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- MFSDELSXOVOZBJ-UHFFFAOYSA-M sodium;dodecyl sulfate;propane-1,2,3-triol Chemical compound [Na+].OCC(O)CO.CCCCCCCCCCCCOS([O-])(=O)=O MFSDELSXOVOZBJ-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Description
FORM 10 ~f 7 4 COMMONWEALTH OF AUSTRALIA PATENTS ACT 1952 COMPLETE SPECIFICATION
(ORIGINAL)
FOR OFFICE USE: Class Int Class Complete Specification Lodged: Accepted: Published: Priority: Related Art: 1198 documnt contains t anwmdweats mdec tlder s ctioa 49.
and il m et for prinzting.
09 1 00. Name and Address of Applicant: 1P 0 0 0 000 00 0...Address for Service: Dental Kagaku Kabushiki Kaisha Tsukijichuo Bldg.
2-11-10, Tsukiji Chuo-ku, Tokyo
JAPAN
Spruson Ferguson, Patent Attorneys Level 33 St Martins Tower, 31 Market Street Sydney, New South Wales, 2000, Australia 7'
I
43 00 0' 0 0 *0 00 a Complete Specification for the invention entitled': _Dentifrice compositions The following statement is a full description of this invention, including the best method of performing it known to me/us 5845/3 Abstract of the disclosure Disclosed is a dentifrice composition for preventing dental caries, the dentifrice composition containing hydroxyapatite in 'which glucanase is immobilized.
'too g C 6* 00 e100 St 00 e 9t*t .00 00*0 6@
S
000
S.
00 06* 00 S S
OS
50 0 0 @000 SO @0 0 C
S
00 0 50 So
I
1 1 j r )69 at a *O 666 Title of the Invention Dentifrice compositions conp 'o \xosioe.
Background of the Invention Field of the Invention This present invention generally relates to a dentifrice composition for preventing dental caries and, more particularly, to a dentifrice composition containing hydroxyapatite in which glucanase and the like are immobilized.
"Glucanase" is a general term for glucan decomposing enzymes.
However, it is understood that the term "glucanase" used herein refers to levanase which decompose levan, dextranase which decompose dextran, and mutanase which decomposes mut an.
Description of the Prior Art It is well-known that the occurrence of dental caries is due to dental plaque which is formed on the surface of teeth by way of polysaccharides produced by a variety of oral bacteria. It is believed that the prevention of dental caries is achieved by the removal of such dental plaque. Levan, mutan and dextran are all polysaccharide produced by oral bacteria, and it has been ascertained that they are a factor in the formation of dental plaque.
Of the enzyme which decompose such polysaccharides, it is well known that dextranase provides a dentifrice composition having an improved effect for prevention of I t rj 6e a *i a SI L
I\
I
r 12 The claims defining the invention are as follows: dental caries, since it is capable of dissolving dental plaque due to its dextran-decomposing capability, as disclosed in the specification of Japanese Patent Registration No, 782,154. When the enzyme is incorporated in a dentifrice products, however, it is easily decomposed and deactivated owing to its relative instability. To keep it in a stable state, use of an appropriate stabilizer is required.
Dextranase in also used with a variety of stabilizers.
For instance, it has been proposed to use dextranase O with a terpene hydrocarbon or aliphatic alcohol base perfume (Japanese Patent Registration No. with carvone or S, -mentol in a specific ratio (Japanese Patent Application t 6 Laid-Open No. 56-110609), or with aluminium oxide to be used as a polishing agent (Japanese Patent Application Laid Open No. 56-63915). It may be presumed that use of an enzyme, to say nothing of dextranase, for a dentifrice e on S .O would require the incorporation of a stabilizer as is aQ the case with dextranase. Since a dentifrice is used in a the mouth, it should be safe and impart a refreshing O. feeling. As a matter of course, considerable restrictions S are presumed to be imposed upon the selection of stabilizes.
C
For this reason, dentifrice compositions containing mutanase or levanase have not been realized, despite the fact that C| ithey are considered effective in the prevention of dental Scaries.
Summary of the Invention An object of the present invention is to provide C 'a N 0T 2 .4
I
a dentifrice composition containing as enzyme, particularly a polysaccharide-decomposing enzyme useful for the prevention of dental-caries, more particularly levanase, dextranase or mutanase, which eliminates problems related to safety and user sensation arising from the use of stabilizers, and which exhibits stable enzymatic activity over an extended period of time without recourse to use any stabilizer. Since enzymes are relatively unstable and soluble, it is well-known that it is better to immobilize them for more efficient use. Generally, immobilized enzymes are found to be stable even in the form of an aqueous solution. While there are a variety of methods for immobilizing enzymes, the classic method relies upon 4 V physical adsorption. As is the case with active carbon, kaolinite, terra abla and the like, hydroxyapatite is used Sas the carrier for immobilizing enzymes by physical C C, adsorption and is known to be suitable for use as a polishing Sagent. It is thus presumed that if levanase, dextranase and mutanase are immobilized with hydroxyapatite, it might o then be possible to prepare an enzyme-containing dentifrice Scomposition which dispenses with any stabilizer. As a result of intensive studies made on such presumption, the present inventors have succeeded in developing a method Si of immobilizing these enzymes with hydroxyapatite. That is, hydroxyapatite used as a polishing agent is added to the solution containing glucanase and protein such as lysozyme, -3- -4albumin, casein and cytochrome C which can be strongly absorbed to hydroxyapatite and which are harmless to human body, then glutaraldehyde solution is added dropwise to those solution under vigorous stirring at below room temperature, and the solution is stirred for several hours to complete the reaction at same temperature after the addition of glutaraldehyde solution. The immobilized hydroxyapatite is obtained by the centrifutation.
Thus according to this invention there is provided a dentifrice composition containing hydroxyapatite having a glucanase or the like immobilized therein.
As the immobilized hydroxyapatites are easily prepared by this process, dentifrice compositions that do not contain a stabilizing agent but glucanase and that have an improved effect upon the prevention of dental caries are prepared by using such hydroxyapatite as the polishing agent according to the conventional dentifrice formulation recipe.
*Table 1 shows the glucanase immobilized hydroxyapatite prepared by the method shown in the specification.
04 /9 of 1 0 z^a *ea aa a ABLE 1 Type Amt. of Apatite No. Type Amt. of Protein Type Amt. of Glucanase GI utaraldehyde 1., 2.
3.
4.
7.
8.
12.
13.
lysozyme O.lg lysozyme 0.lg casein O.1g cytochromie C 0.1g, lysozyme O.lg lysozyme O.Ig 1ysozyme 0.1g lysozyme 0.2g albumin 0.5g lysozyme 0.059 lysozyme 0.05g lysozyme 0.025g lysozyme 0.0125g levanase 0.lg levanase 0.lg levanase 0.lg levanase 0.Ig levanase 0.lg mutanase 0.Ig mutanase 0.lg dextranase 0.2g dextranase 0.05g dextranase 0.2g dextranase 0.2g dextranase 0.025g dextranase 0.0125g dextranase 0.05g hydroxyapatite 2g hydroxyapatite 2g hydroxyapatite 2g hydroxyapatite 2g hydrkxyapati te 2g hydroxyapatite 2g hydroxyapatite 2g hydroxyapatite 5g hydroxyapatite 5g hydroxyapati te 59 hydroxyapatite 5g hydroxyapati te 2.5g hydroxyapatite 2.5g hydroxyapatite 59 1. 12mg 0.56mg 0.56mg 0.56mg /4.48mg 8. 96mg 18.0mg 0 S. Oa~g 0.5-.19 10mg 50mg 50mg 0. 135mg 10.3mg 9.7mg 10.3mg 13.2mg 15.3mg 16.4mg 17.4mg 31.5mg 10. 9mg 9.94mg 15.2mg 8.75mg 12.37mg 0.47g 0.42g 0. 44g 0-499 0.32g 0. 13g 0.02g 0. 0.51g 0. 62g 0.46g 0.06g 0 14. cytochrome C 0.05g 12.15mg 0.46g total banded protein/grams of apatite amount of substrate decomuposition/graffs of protein TMS/91 Ic I I 4b For a better understanding of the invention and to show how the same may be put into effect, reference will now be made, by way of example, to the following working and reference examples.
Example 1: Paste Dentifrice (weight Levanase-immobilized hydroxyapatite Calcium phosphate CMC sodium salt Carrageenan Glycerin 13.2 25.0 0.3 1.2 10.0 ccc M o Oa 4 51 Q aa :19
I
TMS/911c Sorbitol 15.0 Sodium lauryl sulfate Perfume 1L.2 Saccharin sodium-salt 01 silica water 30.0 Example 2 :Paste Dentifrice Mutanase-immobilized hydroxyapatite 20.0 ~*Calcium pyrophosphate. 10.0 0MG sodium salt tlac Garrageenan0.
Glycerin 20.0 Sorbitol 10.0 Sodium lauryl sulfate Perfume Saccharin sodium salt 0.1 Silica Potassium chloride Magnesium chloride 0.3 S Sodium phosphate Water 30.0 Example 3: Paste Dentifrice Dextranse-immobilized hydroxyapatite 35.5 0MG sodium salt Garrageenan 0.3 Glycerin Sodium lauryl sulfate Perfume Saccharin sodium salt Silica Sodium chloride Magnesium chloride Potassium chloride Water 35.5 0.1 2.
0.1.
20I0 4,~4 4 4 4404 0 4 o 4 4 0440 4 4004 44 4, 4 444 44 44' 444 4 4,4 04 4 4 44 o 4.4 43 4 44*44 44 44 44 4 4 4 44 41 4 t~ Example 4 :Powder Dentifrice Dextranase-immobilized hydroxyapatite Sodium lauryl sulfate Perfume Saccharin sodium salt Sodium chloride Magnesium chlori de Example 5 :Lubricating Dentifrice Dextranznse-immobilized hydroxyapatite Calcium phosphate Sorbitol Sodium laurly sulfate Perfume Sodium chloride Magnesium chloride 90.8 0.2 63.0 10.0 10.0 3.3 0.08 -6 ;a Saccharin Water 0.12 10.0
I
Reference Example 1, Preparation of Dextranase-immobilized hydroxyapatite Five hundred (500)mY of potassium phosphate buffer solution having a concentration of 0.05 moles and a PH value of 6.8 was added to a mixture of 50mg of dextranase, of lysozyme, and 5g of hydroxyapatite used as a polishing agent. Five hundred (500)/,0 of a 0.2% aqueous solution of glutaraldehyde was added dropwise under agitation at 4°C to the resulting solution, and stirring was thereafter continued at 4°C for 5hr. The reaction product was collected and was washed three times with 100mfof the aforesaid buffer solution to remove any unreacted matter, Subsequent freeze-drying yielded 5.06g of a powder. About lg of the aforesaid powder was weighed exactly and twenty (20)mR of a potassium phosphate buffer solution having a concentration of 1 moles and a PH value of 6.8 was added to the weighed powder, and stirring was carried out for 3hr, followed by centrifugation. The precipitate was washed with buffer solution and the filtrate were combined to measure the amount of protein contained therein by the lowry method, and the precipitate was washed with pure water to be dried and weighed. It was confirmed that 10.9mg protein was adsorbed to gram of the 44 0 P0 040 4O £1 YY. ~d 7 Ii i dried hydroxyapatite. Measurement of the dextianase activity of such protein by a method to be described later indicated that 0.513g of dextran per gram of the adsorbed protein was decomposed within 2hr.
Preparation of Levanase-immobilized hydroxyapatite Fifty (50)mJ of pure water was added to a mixture of 100mg lysozyme, 100mg levanase and 2g hydroxyapatite, followed by cooling down to 4*C. Two (2)mj of an aqueous solution containing 28mg glutaraldehyde in 300m 9 water was slowly added dropwise under vigorous agitation to the resulting solution, while the temperature of 4 0 C was maintained.
Thereafter, stirring was continued at that temperature for 2hr. Centrifugation yielded a solid which was washed three times with 50mR pure water and then subjected to freeze-drying to obtain 2.05g powder. Analysis effected in the same manner as in indicated that 11.7mg of protein was bonded to gram of hydroxyapatite. Measurement of the levanase activity of the adsorbed protein, effected by the following method, indicated that 0.47g of levan was decomposed per gram of the protein adsorbed to hydroxyapatite.
Preparation of mutanase-immobilized hydroxyapatite The same conditions as in were applied, except that mutanase was used in place of levanase, to obtain immobilized hydroxyapatite. Analysis effected in the same manrer as in indicated that 15.0mg protein was bonded to per gram of hydroxyapatite. Measurement of the 4- 8 S 4i mutanase activity, effected in the manner to be described below, indicated that 0.48g of mutan was decomposed per gram of the bonded protein.
Reference Example II Measurement of the titer of immobilized hydroxyapatite A precisely weighed amount of each sample (lmS of the undried sample before freeze-driying for immobilized hydroxyapatite and 2g of the sample for dentifrice 2 was added to 10m of a potassium phosphate buffer solution )1 containing 1% of each substrate and having a PH value of and a concentration of 0.05 mole, and the resulting solution was stirred at 35" for 2hr, followed by centrifugation. The residue was washed with the same buffer solution, and was combined with the centrifugate to determine the amount of each decomposition product. In the case of dextranase, the substrate was dextran, and the S0' amount of the decomposition product glucose was measured Sby the glucose oxidase method. In the case of mutanase, the substrate was mutan, and the amount of the decomposition product glucose was measured by the same method. In the case of levanase, the substrate was levan, and the amount of the decomposition product fluctose was determined by high performance liquid-chromatography.
Reference Exmaple III The following are thb results of measuring the 1 temporal change in the enzymatic activity of the dentifrice
I
4 -9- 3 d r I i) sample prepared in Exmaple 1,2 and 3.
change in specific activity with time at 37° and PH (activity value just after preparation is taken as being 100) Ex. 1 Ex. 2 Ex. 3 100 100 100 154.0 155.0 327.0 40days 84.7 85.3 185.5 60days 70.5 68.4 125.4 80days lOOdays 60.3 52.2 55.4 46.4 96.4 84.3 010 r 0
I
I f~ It
I
A
It was evident that the dentifrice containing the immobilized hydroxyapatite obtained by the present method exhibits an increase in activity from just after preparation and reaches the peak activity value after the passage of a certain period of time, following which there is a gradual decline in activity. However, the dentifrice maintained a higher enzymatic activity over an extended period, as compared with its initial activity.
The dentifrice composition according to the present invention comprise hydroxyapatite in which enzymes such as levanase, dextranase and mutanase useful for the prevention of dental caries are immobilized. It dispenses with any stabilizer and excels in stability, unlike the conventional enzyme containing dentifrice. The dentifrice composition of the present invention is also advantageous in that it can be prepared by using the immobilized IO-:a 10 L .l.J i\ i hydroxyapatite obtained in the present invention in place of the conventional polyshing agent in the conventional manner without recourse to any special procedure,.
I K. It 41
I
a 'I I
I
11
Claims (6)
1. A dentifrice composition containing hydroxyapatite having a glucanase or the like immobilized therein.
2. The dentifrice composition according to claim 1 wherein the glucanase is levanase.
3. The dentifrice composition according to claim 1 wherein the glucanase is dextranase.
4. The dentifrice composition according to claim 1 wherein the glucanase is mutanase.
A dentifrice composition containing hydroxyapatite having a glucanase or the like immobilized therein, substantially as hereinbefore described with reference to any one of Examples 1 to 5 or Reference Example 3.
6. A method of preventing dental caries in a patient, comprising administering to the oral cavity of the patient an effective amount of a dentifrice composition according to any one of claims 1 to DATED this FIRST day of MAY 1990 Dental Kagaku Kabushiki Kaisha Cr C.) SC U T Patent Attorneys for the Applicant SPRUSON FERGUSON ft S S S: S 555 I :1 c 4i"l I: t 6: I: 4 -4 S S S t 5 1 TMS/911c 4
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9133386A JPH0228563B2 (en) | 1986-04-22 | 1986-04-22 | HAMIGAKISOSEIBUTSU |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU7460087A AU7460087A (en) | 1989-01-05 |
| AU599387B2 true AU599387B2 (en) | 1990-07-19 |
Family
ID=14023513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU74600/87A Ceased AU599387B2 (en) | 1986-04-22 | 1987-06-23 | Dentifrice compositions comprising hydroxyapatite in which glucanase is immobilized therein |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JPH0228563B2 (en) |
| AU (1) | AU599387B2 (en) |
| DE (1) | DE3721443C2 (en) |
| FR (1) | FR2617710B1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6470408A (en) * | 1987-09-10 | 1989-03-15 | Hairu Kk | Dentifrice composition |
| JP4724616B2 (en) * | 2006-07-20 | 2011-07-13 | ミンクルプロダクツ株式会社 | Toothpaste |
| RU2494725C1 (en) * | 2012-08-20 | 2013-10-10 | Общество С Ограниченной Ответственностью "Сплат-Косметика" (Ооо "Сплат-Косметика") | Mineral enzymatic complex for enamel strengthening and whitening, oral hygiene composition and tooth paste |
| CN111154744B (en) * | 2019-12-24 | 2022-02-01 | 克劳丽化妆品股份有限公司 | Hydroxyapatite immobilized alpha-glucanase and preparation method and application thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1938189A1 (en) * | 1969-07-28 | 1971-02-25 | Blendax Werke Schneider Co | Dental and oral care products containing enzymes |
| DE2937964C2 (en) * | 1979-09-20 | 1982-11-11 | Peter 3400 Göttingen Schilling | Means to fight tooth decay |
| JPS5663915A (en) * | 1979-10-27 | 1981-05-30 | Lion Corp | Tooth paste composition |
| JPS6267013A (en) * | 1985-09-20 | 1987-03-26 | Dentaru Kagaku Kk | Dentifrice composition |
| JPS6269988A (en) * | 1985-09-20 | 1987-03-31 | Dentaru Kagaku Kk | Hydroxyapatite having stably immobilized dextranse and production thereof |
-
1986
- 1986-04-22 JP JP9133386A patent/JPH0228563B2/en not_active Expired - Lifetime
-
1987
- 1987-06-23 AU AU74600/87A patent/AU599387B2/en not_active Ceased
- 1987-06-29 DE DE19873721443 patent/DE3721443C2/en not_active Expired - Fee Related
- 1987-07-10 FR FR8709865A patent/FR2617710B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0228563B2 (en) | 1990-06-25 |
| AU7460087A (en) | 1989-01-05 |
| DE3721443A1 (en) | 1989-01-12 |
| DE3721443C2 (en) | 1994-04-14 |
| FR2617710A1 (en) | 1989-01-13 |
| JPS62249917A (en) | 1987-10-30 |
| FR2617710B1 (en) | 1990-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3911104A (en) | Gel dentifrices | |
| CA2098525C (en) | Oral composition | |
| CA1300516C (en) | Oral compositions | |
| GB2045081A (en) | Bad breath preventive agent | |
| RU2287322C2 (en) | Antibacterial preparation for cleaning teeth of improved properties against dental covering and for refreshed breathing | |
| JP2000508323A (en) | Composition for the removal of plaque | |
| US4138476A (en) | Plaque dispersing enzymes as oral therapeutic agents by molecular alteration | |
| AU602149B2 (en) | Apatite immobilized glucanase and the like, and method of preparing the same | |
| AU599387B2 (en) | Dentifrice compositions comprising hydroxyapatite in which glucanase is immobilized therein | |
| CN100335028C (en) | Oral composition providing enhanced oral hygiene properties | |
| US4740368A (en) | Amylase containing breath cleansing confection | |
| CA1281658C (en) | Dentifrice compositions | |
| JP2001520179A (en) | Plaque inhibiting oral composition | |
| JP3336688B2 (en) | Oral composition | |
| JPH115722A (en) | Aqueous composition for washing oral cavity | |
| CA2590211C (en) | Oral treatment compositions containing an anti-adhesion agent, antibacterial agent and incompatible compound | |
| JPS59152317A (en) | Composition for oral cavity | |
| JPH0136802B2 (en) | ||
| JPH01250304A (en) | Skin cosmetic | |
| JPH11349462A (en) | Oral composition | |
| JPH04217613A (en) | Composition for oral cavity | |
| JP2001089341A (en) | Bacterial adhesion inhibitor | |
| JP2002370957A (en) | Oral composition | |
| JPH1121217A (en) | Oral composition | |
| JPH04173070A (en) | Sweetness composition |